Authors’ reply to Das et al.-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Authors’ reply to Das et al.

Published:2024-04 Issue:2 Volume:7 Page:260-261
ISSN:2590-3233
Container-title:Cancer Research, Statistics, and Treatment
language:en
Short-container-title:

Author:

Jha Prerana¹²,Prabhash Kumar³,Kumar Prashant¹²⁴

Affiliation:

1. Advanced Center for Cancer Research and Diagnosis, Karkinos Healthcare Pvt Ltd, Navi Mumbai, Maharashtra, India

2. Karkinos Foundation, Mumbai, Maharashtra, India

3. Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, Maharashtra, India

4. Center of Excellence for Cancer, Gangwal School of Medical Sciences and Technology, Indian Institute of Technology Kanpur, Kanpur, Uttar Pradesh, India

Publisher

Medknow

Reference6 articles.

1. NUT midline carcinoma:An unknown therapeutic territory;Das;Cancer Res Stat Treat,2024

2. NUT-midline carcinoma of the lung with rare BRD3-NUTM1 fusion;Jha;Cancer Res Stat Treat,2024

3. NUT Carcinoma:Clinicopathologic features, pathogenesis, and treatment;French;Pathol Int,2018

4. NUT carcinoma:A rare case series;Majumdar;Indian J Cancer,2023

5. Immunohistochemical markers to diagnose primary squamous cell carcinoma of the lung:A meta-analysis of diagnostic test accuracy;Chen;Ther Adv Med Oncol,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP